Ibere Pharmaceuticals (IBER-UN) Financial Statements
Ibere Pharmaceuticals (IBER-UN) files with the U.S. Securities and Exchange Commission under CIK 0001835205. 10KGenie shows its annual and quarterly statements from SEC filings.
Key Figures, Fiscal Year 2021
- Net Income (Loss)
- $1.56 million
- Total Assets
- $138.71 million
- Net Cash from Operations
- -$868.75 thousand
Fiscal year ended Dec 31, 2021. Latest periodic SEC filing: Nov 14, 2022. Source: SEC filings (EDGAR XBRL).
Open the full financial statements for IBER-UN in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History